Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus sulphonylurea and/or pioglitazone in people with type 2 diabetes fasting during Ramadan
2011-000284-27Phase 4Completed
- Sponsor
- University of Leicester
- Start
- Mar 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Metformin + liraglutide, Metformin + sulphonylurea and Metformin + pioglitazone (3 arms). Primary endpoint: Primary composite endpoint. Started Mar 2011; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-000284-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000284-27.